Pro-inflammatory and pro-thrombotic biomarkers such as CRP, IL-6, TNF-α, fibrinogen and plasminogen activator inhibitor-1 have all been found to be associated with MetS, however these relationships and potential role in pathogenesis are not well understood [39, 40]. Here, IL6 is linked to metabolic syndrome.